Tri-iodothyronine enhances liver regeneration after living donor liver transplantation in rats

12Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Tri-iodothyronine (T3) has been shown to be a hepatic mitogen. The aim of this study was to evaluate the effect of T3 on liver regeneration after 50% partial liver transplantation (pLT) in rats. Methods: Immediately after pLT, a single dose of T3 (4 mg/kg body weight) was administered. Liver/body weight ratio (LBWR), hepatocyte proliferation (Ki-67), biochemical parameters, and changes in cell cycle related proteins were evaluated. Results: T3 promoted liver regeneration as shown by an increased liver/body weight ratio and Ki-67 proliferation index after pLT. On the transcriptional level, T3-treated rats had an increased expression of cyclin D1 and cyclin A as demonstrated by real time RT-PCR and Western blot. Conclusions: Exogenous administration of T3 significantly improved liver regeneration after pLT, and therefore it may represent a promising strategy to improve the clinical outcome after living donor liver transplantation in the future. © 2011 Japanese Society of Hepato-Biliary-Pancreatic Surgery and Springer.

Cite

CITATION STYLE

APA

Taki-Eldin, A., Zhou, L., Xie, H. Y., Chen, K. J., Zhou, W. H., Zhang, W., … Zheng, S. S. (2011). Tri-iodothyronine enhances liver regeneration after living donor liver transplantation in rats. Journal of Hepato-Biliary-Pancreatic Sciences, 18(6), 806–814. https://doi.org/10.1007/s00534-011-0397-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free